Clinical Trial Update: Safety Study of Modified Vaccinia Virus to Cancer [Phase 1]

View source ↗

Summary

Phase 1 safety study of Modified Vaccinia Virus in cancer patients has completed, evaluating safety across multiple cancer types including melanoma, breast canc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Colorectal Cancer
• Head and Neck Squamous Cell Carcinoma
• Hepatocellular Carcinoma
• Melanoma
• Pancreatic Adenocarcinoma

Drugs mentioned

• Modified Vaccinia Virus (modified vaccinia virus)

Snippet

Sponsor: David Bartlett | Conditions: Melanoma, Breast Cancer | Phase 1 | Status: COMPLETED